THE PATENT THAT MAKES THE DIFFERENCE AT THE THERAPEUTIC LEVEL
THE FIRST EVOLUTION OF CARBOMED
Carbomed CDT Evolution (Carbon Dioxide Therapy Evolution), today known simply as CDT Evolution, is the first result of the company’s technical innovation.
The first patent for electronic flow control is implemented. (2006) with the addition of the possibility to control the temperature, sterility and humidity of the carbon dioxide supplied.
Moreover thanks to the contribution of the GISC studies, we have updated the software of the device and standardized programs dedicated to aesthetic and fusion medicine, anti-aging treatments, ulcers and difficult wounds.
CDT Light (short for Carbomed CDT Evolution Light) was developed (2009) to address the transport and space requirements in medical practices.
It keeps the same patent of CDT Evolution for the detection of subcutaneous impedances, but it does not calculate the same algorithms, so it does not have standardized programs and it is necessary to set the parameters manually (eg manual regulation of the temperature).